Grants for Public and State controlled institutions of higher education - Federal

The FY24 DMDRP CTRA mechanism supports advanced translational research that will accelerate the movement of promising ideas in DMD research into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. However, applicants should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between applied and clinical research. As such, applications must include preliminary and/or published data relevant to DMD to support the proposed research project.This mechanism is intended to support established projects that have moved beyond the realm of basic research and proof of concept studies and have the potential to result in a near-term impact in clinical research or the clinic. Research projects investigating therapies that will be efficacious across the life span, including infants, toddlers, and non-ambulatory individuals, are strongly encouraged. Pilot, proof-of-principle clinical trials, and correlative studies to better inform development of drugs, devices, and other interventions are allowed.Early-Career Partnering PI Option: The FY24 DMDRP encourages applications that include meaningful and productive collaborations between investigators. In an effort to promote enhanced research capacity within the DMD field, the FY24 CTRA includes an option for an Early-Career Partnering Principal Investigator (PI). The Partnering PI Option is structured to accommodate two PIs. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The Early-Career PI will be identified as the Partnering PI. Both PIs should contribute significantly to the development and execution of the proposed research project. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). Each award will be subject to separate reporting, regulatory, and administrative requirements. For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission.The FY24 DMDRP CTRA offers two funding levels (refer to Section II.D.5 Funding Restrictions). Only one funding level category may be chosen per application, and the choice of application category is at the discretion of the applicant. The following are generalized descriptions of the scope of the research appropriate for each funding level:Funding Level 1: Funding Level 1 is intended to support smaller, less complex preclinical and/or clinical research. Pilot clinical trials are allowed. The proposal/applications direct costs budgeted for the entire period of performance should not exceed $650,000.Funding Level 2: Funding Level 2 is intended to support larger, more complex preclinical and/or clinical research. Pilot clinical trials are allowed. The proposal/applications direct costs budgeted for the entire period of performance should not exceed $1.35M.Additionally, both funding levels will support an Early-Career Partnering PI Option at the same maximum direct costs and periods of performance, respectively.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Both pilot clinical trials and clinical research are permitted under this mechanism.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.All investigators applying to FY24 DMDRP funding opportunities and conducting clinical research are encouraged to consult the Strategies to Promote Diversity in Muscular Dystrophy Research Participation developed by the MDCC.

This grant provides funding for research aimed at understanding and addressing schizophrenia and related disorders in individuals aged 35 and older, targeting a wide range of eligible applicants including universities, nonprofits, and businesses.

This funding opportunity provides financial support for diverse doctoral students conducting research on aging and related health issues, helping to cultivate a more inclusive scientific workforce.

This funding opportunity supports U.S. and Italian organizations in creating programs that strengthen cultural ties and promote shared values between the United States and Italy, focusing on democracy, economic prosperity, and countering disinformation.

The purpose of the Nurse Education, Practice, Quality, and Retention (NEPQR)-Workforce Expansion Program (WEP) is to increase the nursing workforce in rural (non-metro) and underserved areas to address the critical shortage of nurses, specifically in acute and long-term care settings.

This funding opportunity supports researchers exploring innovative strategies to achieve long-lasting HIV remission at the start of antiretroviral therapy, focusing on basic and preclinical studies rather than clinical trials.

This program provides funding to Hispanic-Serving Institutions to improve educational and community development initiatives in food, agriculture, natural resources, and human sciences, with a focus on supporting underrepresented students and enhancing workforce readiness.

This funding opportunity provides financial support for the design and operation of a facility that extracts and refines rare earth elements from unconventional sources, aimed at strengthening domestic supply chains and reducing reliance on foreign materials.

Grant Title: Racial Equity in STEM Education - This grant aims to fund projects that promote racial equity in STEM education by addressing systemic racism and involving those affected in leadership and decision-making.

The National Endowment for the Humanities (NEH) Office of Challenge Programs is accepting applications for Graduate Education in the Humanities: A National Convening, a cooperative agreement to plan and host a national convening to evaluate the current state of graduate education in the humanities, to make recommendations for programs to prepare graduate students for a variety of humanities-related careers, and to develop a roadmap that articulates a strategic vision for graduate education in the humanities. The project will be funded through a combination of federal matching funds and related fundraising from non-federal third parties.

Project is to increase the capacity of partner countries to develop, adopt, and implement legal frameworks that protect individual data privacy while educating key stakeholders and enabling trusted cross-border data flows and digital trade.

This funding opportunity announcement (FOA) invites research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Both animal and human subjects research projects are welcome. Researchers proposing basic science experimental studies involving human participants should consider the companion FOA TEMP-14931 "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)".

The U.S. Department of State, Bureau of Democracy, Human Rights, and Labor (DRL), in coordination with the Bureau of East Asian and Pacific Affairs (EAP), announces an open competition for organizations interested in submitting applications for a project that will increase sub-national, democratic, and people-to-people ties between Central and Eastern Europe (CEE) and Taiwan. For the purposes of this solicitation, applicable regions include Central and Eastern Europe, the Baltic states, and the Western Balkans.

This notice announces the opportunity to apply for funding under the Center for Maternal and Child Health Medicaid Partnerships program. The purpose of the Center for Maternal and Child Health Medicaid Partnerships is to strengthen collaboration between state Medicaid, Childrens Health Insurance Program (CHIP), and Title V Maternal and Child Health Services Block Grant (Title V) programs and advance innovative financing strategies that improve outcomes and reduce health disparities for maternal and child health (MCH) populations. The award recipient will build knowledge and shared priorities between state Medicaid, CHIP, and Title V programs and provide one-to-one, state-specific tailored capacity-building assistance directly to state Medicaid, CHIP, and Title V programs to support MCH. Support will include: (1) engaging state Title V, Medicaid, and CHIP programs to identify shared priorities and foster a common understanding of needs, opportunities, and best practices; (2) one-to-one, state-specific, tailored assistance to advance MCH financing; (3) support the development of innovative collaborative models leveraging HRSA, CHIP, and Medicaid funding, and (4) one-to-one capacity-building assistance to advance interagency agreements required by statute.

This funding opportunity provides $3.5 million over five years to organizations that will create a national resource hub for improving healthcare access and outcomes in rural communities across the United States.

The U.S. Embassy Port Louis Public Diplomacy Section (PDS) of the U.S. Department of State announces an open competition for organizations or individuals to submit a Statement of Interest (SOI) to carry out a program (or programs) to promote bilateral relationships between the U.S. and Mauritius and Seychelles. Please carefully read and follow all instructions below. The submission of the SOI is the first step in a two-step process. Applicants must first submit a concise (1500 word) statement of interest designed to clearly communicate program ideas and objectives. This is not a full proposal. The purpose of the SOI process is to allow applicants to submit program ideas for evaluation prior to requiring the development of a full proposal application. Upon a merit review of eligible SOIs, selected applicants will be invited to expand on their program idea(s) by submitting a full proposal application. Full proposals will go through a second merit review before final funding decision are made. Two-round process: In Round 1, applicants submit a concise Statement of Interest (SOI) of no more than 1,500 words that describes the program ideas and their objectives. The Public Diplomacy Section will review SOIs and invite a limited group of applicants to continue in Round 2. In Round 2, applicants expand their ideas into full funding proposals for formal consideration. SOIs may be submitted for consideration through June 1, 2024. Please download the template found here and then submit your Statement of Interest to [email protected]. Successful SOI applicants will be notified via email on or around June 15, 2024. Instructions on the requirements of a full application submission will be provided at that time and full proposals will be due by July 15, 2024. Additional Information at: https://mu.usembassy.gov/education-culture/grants-programs/rsoi-2024/

This funding opportunity supports institutions in training clinical scientists focused on cancer research, enabling them to lead or participate in clinical trials as part of their career development.

The National Science Foundation's Directorate for Biological Sciences (BIO) will support up to 10 awards annually to enable active research by cohorts of middle school teachers, high school teachers and/or community college faculty. Research Experiences for Teachers Sites (RET Sites; RETS) will be based at institutions of higher learning or other non-profit organizations in the U.S. that conduct educational and research activities. RETS with a focus on Biological Sciences (BIORETS) will include research projects in fields that are supported by the Directorate for Biological Sciences. BIORETS may be based in a single discipline or department or may offer interdisciplinary or multi-department research opportunities with a coherent intellectual theme. An important goal of the program is to increase the participation of underrepresented groups in biological research and those from geographically underrepresented areas in science, technology, engineering, and mathematics (STEM). Proposals are strongly encouraged to involve members of these groups both as participants and as mentors. BIORETS awards are expected to leverage the teachers research experiences for curriculum development, with the goal of enriching their classroom teaching practices and inspiring a broad swath of students to consider higher education and careers in STEM. Teachers supported with NSF funds in BIORETS projects must be U.S. citizens, U.S. nationals, or permanent residents of the United States.

(Reissue PAR-21-058). The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable the rigorous validation of biomarker measurements within the clinical population of interest to establish the positive and negative predictive values of the candidate biomarker consistent with FDA guidelines. This PAR assumes that 1) a candidate biomarker has already been identified, 2) detection method technology has already been developed and analytically validated, and 3) the research and/or clinical need and potential context of use has been identified.

This grant provides funding for research on the Earth's tectonic processes, supporting universities and non-profit organizations in exploring geological deformation and plate movements through various scientific methods.